News & Updates
Filter by Specialty:
Apalutamide for castration-resistant prostate cancer yields real-world results
25 Mar 2022
Patients with nonmetastatic castration-resistant prostate cancer (nmCRPC) who have been initiated on apalutamide in a real-world setting appear to show prostate-specific antigen (PSA) response that is strong and consistent with that reported in clinical trials, as reported in a study.
Apalutamide for castration-resistant prostate cancer yields real-world results
25 Mar 2022Light drinking may protect against death after myocardial infarction
24 Mar 2022
byStephen Padilla
Following an episode of myocardial infarction (MI), patients with light or moderate alcohol consumption appear to have a lower risk of mortality than nondrinkers, according to a study.